Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera.

Trehu, E G

Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Aug 1996 - 1341-51 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.

1078-0432


Adult
Aged
Etanercept
Female
HLA-DR Antigens--analysis
Humans
Immunoglobulin G--administration & dosage
Immunohistochemistry
Intercellular Adhesion Molecule-1--analysis
Interleukin-2--administration & dosage
Male
Middle Aged
Neoplasms--chemistry
Receptors, Tumor Necrosis Factor--administration & dosage
Recombinant Proteins--administration & dosage